UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adipose tissue macrophage infiltration and hepatocyte stress increase GDF-15 throughout development of obesity to MASH

Nature communications, 2024-08, Vol.15 (1), p.7173-18

2024

Volltextzugriff (PDF)

Oncogenic plasmid DNA and liver injury agent dictates liver cancer development in a mouse model

Clinical science (1979), 2024-10, Vol.138 (19), p.1227-1248

2024

Volltextzugriff (PDF)

Characterizing alcohol-related and metabolic dysfunction-associated steatotic liver disease cirrhosis via fibrotic pattern analysis

Scientific reports, 2024-10, Vol.14 (1), p.23679-11, Article 23679

2024

Volltextzugriff (PDF)

Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2

Proceedings of the National Academy of Sciences - PNAS, 2024-08, Vol.121 (35), p.e2405746121

2024

Volltextzugriff (PDF)

Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19

World journal of gastroenterology : WJG, 2024-08, Vol.30 (31), p.3705-3716

2024

Volltextzugriff (PDF)

Key regulators of hepatic stellate cell activation in alcohol liver Disease: A comprehensive review

International immunopharmacology, 2024-11, Vol.141, p.112938, Article 112938

2024

Volltextzugriff (PDF)

MOR23 deficiency exacerbates hepatic steatosis in mice

The FASEB journal, 2024-10, Vol.38 (20), p.e70107-n/a

2024

Volltextzugriff (PDF)

Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression

International journal of molecular sciences, 2024-08, Vol.25 (16), p.8641

2024

Volltextzugriff (PDF)

Long-term exposure to polychlorinated biphenyl 126 induces liver fibrosis and upregulates miR-155 and miR-34a in C57BL/6 mice

PloS one, 2024-08, Vol.19 (8), p.e0308334

2024

Volltextzugriff (PDF)

Diagnostic accuracy of FibroScan-AST (FAST) score, non-alcoholic fatty liver fibrosis score (NFS), FibroScan, and liver fibrosis index (FIB-4) for identifying fibrotic non-alcoholic steatohepatitis in patients with chronic hepatitis B with metabolic dysfunction-associated fatty liver disease

Annals of medicine (Helsinki), 2024-12, Vol.56 (1), p.2420858

2024

Volltextzugriff (PDF)

Training robust T1-weighted magnetic resonance imaging liver segmentation models using ensembles of datasets with different contrast protocols and liver disease etiologies

Scientific reports, 2024-09, Vol.14 (1), p.20988-14, Article 20988

2024

Volltextzugriff (PDF)

A combination model of CT-based radiomics and clinical biomarkers for staging liver fibrosis in the patients with chronic liver disease

Scientific reports, 2024-08, Vol.14 (1), p.20230-14, Article 20230

2024

Volltextzugriff (PDF)

Farrerol alleviates insulin resistance and hepatic steatosis of metabolic associated fatty liver disease by targeting PTPN1

Journal of cellular and molecular medicine, 2024-09, Vol.28 (18), p.e70096-n/a

2024

Volltextzugriff (PDF)

Structure-function analysis of time-resolved immunological phases in metabolic dysfunction-associated fatty liver disease (MASH) comparing the NIF mouse model to human MASH

Scientific reports, 2024-10, Vol.14 (1), p.23014-15, Article 23014

2024

Volltextzugriff (PDF)

Diagnostic role of the fibrosis-4 index and nonalcoholic fatty liver disease fibrosis score as a noninvasive tool for liver fibrosis scoring

Medicine (Baltimore), 2024-10, Vol.103 (43), p.e40214

2024

Volltextzugriff (PDF)

Application of liver biopsy in etiological diagnosis of unexplained portal hypertension: Porto-sinusoidal vascular disease should not be ignored

Medicine (Baltimore), 2024-09, Vol.103 (39), p.e39819

2024

Volltextzugriff (PDF)

Far-infrared radiation alleviates steatohepatitis and fibrosis in metabolic dysfunction-associated fatty liver disease

Scientific reports, 2024-08, Vol.14 (1), p.19292-10

2024

Volltextzugriff (PDF)

RANK-RANKL-OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives

International journal of molecular sciences, 2024-09, Vol.25 (17), p.9193

2024

Volltextzugriff (PDF)

RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment

Nature communications, 2024-08, Vol.15 (1), p.7263-20

2024

Volltextzugriff (PDF)

Lacticaseibacillus paracsei HY7207 Alleviates Hepatic Steatosis, Inflammation, and Liver Fibrosis in Mice with Non-Alcoholic Fatty Liver Disease

International journal of molecular sciences, 2024-09, Vol.25 (18), p.9870

2024

Volltextzugriff (PDF)

Mixed active metabolites of the SNP-6 series of novel compounds mitigate metabolic dysfunction-associated steatohepatitis and fibrosis: promising results from pre-clinical and clinical trials

Journal of translational medicine, 2024-10, Vol.22 (1), p.936-18, Article 936

2024

Volltextzugriff (PDF)

Protecting the liver with PKD1

Science signaling, 2024-08, Vol.17 (851), p.eads6258

Wong, Wei

2024

Volltextzugriff (PDF)

Identification of Two Long Noncoding RNAs, Kcnq1ot1 and Rmst, as Biomarkers in Chronic Liver Diseases in Mice

International journal of molecular sciences, 2024-08, Vol.25 (16), p.8927

2024

Volltextzugriff (PDF)

Association between triglyceride glucose-body mass index and the staging of non-alcoholic steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease

Annals of medicine (Helsinki), 2024-12, Vol.56 (1), p.2409342

2024

Volltextzugriff (PDF)

Therapeutic effects of FGF21 mimetic bFKB1 on MASH and atherosclerosis in Ldlr−/−.Leiden mice

The FASEB journal, 2024-10, Vol.38 (20), p.e70087-n/a

2024

Volltextzugriff (PDF)

1 – 25 von 1.269

Suche als RSS-Feed

Aktive Filter

Neu hinzugefügt... seit 90 Tagen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.106)
Mit Volltextzugriff
(1.054)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(899)
Humans
(896)
Life Sciences & Biomedicine
(786)
Male
(759)
Animals
(586)
Female
(449)
Liver Neoplasms - Pathology
(428)
Liver - Pathology
(401)
Mice
(360)
Liver Cancer
(351)
Middle Aged
(351)
Liver
(343)
Carcinoma, Hepatocellular - Pathology
(330)
Liver - Metabolism
(307)
Liver Diseases
(255)
Aged
(248)
Adult
(237)
Hepatocellular Carcinoma
(228)
Oncology
(225)
Liver Neoplasms - Metabolism
(204)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.138)
EZB Electronic Journals Library
(852)
Ingenta
(518)
SpringerLink
(287)
Journals@Ovid
(257)
Nature Journals Online
(167)
Wiley Online Library Journals
(136)
IngentaConnect Journals
(128)
Elsevier ScienceDirect Journals Complete
(101)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(87)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(87)
Nexis Uni
(80)
Publisher's website
(70)
ProQuest Dissertations & Theses A&I
(59)
Wiley Online Library
(53)
Taylor & Francis Journals
(25)
Taylor & Francis
(22)
Taylor & Francis Online
(19)
BMJ
(17)
SAGE Complete
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Scientific Reports
(97)
International Journal Of Molecular Sciences
(63)
Bmc Cancer
(37)
Plos One
(29)
Nature Communications
(25)
World Journal Of Gastroenterology : Wjg
(23)
Bmc Gastroenterology
(18)
Cells
(18)
Cancer Medicine
(17)
Frontiers In Immunology
(17)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(277)
... seit 7 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Adipose tissue macrophage infiltration and hepatocyte stress increase GDF-15 throughout development of obesity to MASH

Oncogenic plasmid DNA and liver injury agent dictates liver cancer development in a mouse model

Characterizing alcohol-related and metabolic dysfunction-associated steatotic liver disease cirrhosis via fibrotic pattern analysis

Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2

Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19

Key regulators of hepatic stellate cell activation in alcohol liver Disease: A comprehensive review

MOR23 deficiency exacerbates hepatic steatosis in mice

Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression

Long-term exposure to polychlorinated biphenyl 126 induces liver fibrosis and upregulates miR-155 and miR-34a in C57BL/6 mice

Diagnostic accuracy of FibroScan-AST (FAST) score, non-alcoholic fatty liver fibrosis score (NFS), FibroScan, and liver fibrosis index (FIB-4) for identifying fibrotic non-alcoholic steatohepatitis in patients with chronic hepatitis B with metabolic dysfunction-associated fatty liver disease

Training robust T1-weighted magnetic resonance imaging liver segmentation models using ensembles of datasets with different contrast protocols and liver disease etiologies

A combination model of CT-based radiomics and clinical biomarkers for staging liver fibrosis in the patients with chronic liver disease

Farrerol alleviates insulin resistance and hepatic steatosis of metabolic associated fatty liver disease by targeting PTPN1

Structure-function analysis of time-resolved immunological phases in metabolic dysfunction-associated fatty liver disease (MASH) comparing the NIF mouse model to human MASH

Diagnostic role of the fibrosis-4 index and nonalcoholic fatty liver disease fibrosis score as a noninvasive tool for liver fibrosis scoring

Application of liver biopsy in etiological diagnosis of unexplained portal hypertension: Porto-sinusoidal vascular disease should not be ignored

Far-infrared radiation alleviates steatohepatitis and fibrosis in metabolic dysfunction-associated fatty liver disease

RANK-RANKL-OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives

RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment

Lacticaseibacillus paracsei HY7207 Alleviates Hepatic Steatosis, Inflammation, and Liver Fibrosis in Mice with Non-Alcoholic Fatty Liver Disease

Mixed active metabolites of the SNP-6 series of novel compounds mitigate metabolic dysfunction-associated steatohepatitis and fibrosis: promising results from pre-clinical and clinical trials

Protecting the liver with PKD1

Identification of Two Long Noncoding RNAs, Kcnq1ot1 and Rmst, as Biomarkers in Chronic Liver Diseases in Mice

Association between triglyceride glucose-body mass index and the staging of non-alcoholic steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease

Therapeutic effects of FGF21 mimetic bFKB1 on MASH and atherosclerosis in Ldlr−/−.Leiden mice

Aktive Filter

Suchergebnisse filtern